Pharmaceutical Translation Services
Helping pharmaceutical companies communicate globally with confidence.
From clinical development and regulatory submissions to product launches and post-market communications, ALM provides specialist pharmaceutical translation services that help Life Sciences organisations expand internationally while maintaining accuracy, consistency and regulatory confidence.
Whether you’re preparing documentation for the EMA, launching products into new markets or managing multilingual patient information, our specialist pharmaceutical linguists help ensure translations are accurate, consistent and appropriate for their intended purpose.
Supporting pharmaceutical companies throughout the product lifecycle
Pharmaceutical translation is about far more than converting words between languages. Every document contributes to patient safety, regulatory approval and successful market access, meaning accuracy and consistency are essential at every stage.
ALM works with pharmaceutical companies, CROs and Life Sciences organisations to build multilingual workflows that support the complete product lifecycle. Combining specialist pharmaceutical linguists with terminology management, translation memory and structured quality assurance, we help organisations communicate confidently across international markets while reducing complexity over time.
For a translation partner that understands your industry, contact ALM:
Get a Free Quote How compliant is your translation process?Pharmaceutical Content We Translate
Supporting specialist pharmaceutical documentation from clinical
development through to commercial launch and ongoing market support.
Clinical Trial Documentation
Protocols, informed consent forms, investigator brochures, patient recruitment materials and study communications.
Regulatory Submissions
Supporting multilingual documentation prepared for EMA, MHRA and international regulatory authorities.
Patient Information Leaflets (PILs)
Clear, accurate patient-facing translations that help maintain consistency, usability and regulatory compliance.
Summary of Product Characteristics (SmPCs)
Specialist translation of prescribing information and regulated product documentation.
Packaging, Labelling & Artwork
Supporting multilingual packaging, carton copy, labels and artwork updates across global markets.
Pharmacovigilance & Safety Documentation
Translations that support ongoing patient safety, adverse event reporting and regulatory compliance.
Medical & Scientific Publications
Research papers, journals, whitepapers and scientific communications translated by subject specialists.
Marketing & Educational Content
Websites, product brochures, HCP materials, presentations, campaigns and patient education resources.
Visiting The Pharmacy Show 2026?
ALM will be exhibiting at The Pharmacy Show at the NEC Birmingham. If multilingual content, regulatory documentation or international expansion is part of your role, come and speak to our team about how you currently manage translation across your organisation.
Whether you are reviewing translation suppliers, exploring AI-assisted workflows or looking for better control over terminology, quality and multilingual content, book a meeting with us in advance.
Book a Meeting at The Pharmacy Show
11–12 October 2026
Pharmacy Show 2026 • NEC Birmingham
Stand number B75
Opening Times
- 11th October: 9:00am-6:00pm
- 12th October: 9:30am–4:30pm
Why Pharmaceutical Companies Choose ALM
Specialist Pharmaceutical Linguists
Experienced translators with pharmaceutical and Life Sciences expertise, matched to your content and subject matter.
Consistent Terminology
Translation technology, approved glossaries and terminology management help maintain consistency across every language, product and future update.
Quality Without Compromise
ISO-certified processes, specialist review and quality assurance tailored to regulated pharmaceutical content.
AI Where Appropriate
Technology used to improve efficiency, always supported by expert human oversight
Controlled Workflows
Translation, review and QA stages are defined around the content, audience and level of risk, providing appropriate controls for each requirement.
Dedicated Project Management
Experienced Life Sciences project managers coordinating languages, linguists, timelines and review stages.
How Robust Is Your Pharmaceutical Translation Process?
As your organisation grows internationally, multilingual content becomes increasingly difficult to manage.
Take our Pharmaceutical Translation Readiness Assessment to identify opportunities to improve consistency, reduce risk and create a more scalable translation process.
Working with ALM
More than a translation supplier.
Successful pharmaceutical translation relies on structured processes, specialist expertise and long-term control of multilingual content. ALM can support individual translation requirements or help organisations build scalable multilingual workflows across products, languages and markets.
Working with ALM means you’ll benefit from:
- Specialist pharmaceutical linguists with Life Sciences expertise
- ISO-certified translation and quality management
- Translation memory and terminology management
- Human expertise supported by carefully managed AI workflows
- Dedicated Life Sciences project management
- DTP, localisation and multilingual publishing
- Secure handling of confidential documentation
- A scalable partner supporting your international growth
Frequently Asked Questions About Pharmaceutical Translation
ALM supports pharmaceutical companies, CROs and Life Sciences organisations with multilingual content throughout the product lifecycle. This includes clinical trial documentation, regulatory submissions, SmPCs, Patient Information Leaflets (PILs), labelling and packaging, pharmacovigilance and safety content, medical and scientific materials, training and commercial content.
The translation workflow, specialist expertise and level of review can be adapted according to the content, intended audience and associated risk.
Pharmaceutical translation requires more than linguistic accuracy. ALM combines specialist linguists, terminology management, translation memory, defined review stages and quality assurance technology to help maintain accuracy and consistency across languages and successive updates.
The workflow is determined by the content and its intended use, with higher-risk, patient-facing or regulated content receiving the appropriate level of specialist human review.
ALM’s translation processes are certified to ISO 17100 and its quality management system to ISO 9001.
Yes. ALM supports multilingual regulatory and controlled documentation for pharmaceutical organisations, including submission content, SmPCs, PILs, labelling, safety documentation and associated clinical and medical materials.
Specialist linguists, controlled terminology, translation technology and defined review processes help maintain consistency and document integrity across languages, products and updates.
Yes, for appropriate content but the decision should be based on the content and its intended use rather than productivity or cost alone.
ALM can screen content against factors such as regulatory or safety implications, audience, confidentiality, language combination, content complexity and the potential consequences of an error. This helps determine whether AI-assisted or machine translation is appropriate and what level of specialist human editing, review or quality assurance is required.
For higher-risk, patient-facing, safety-critical or regulated pharmaceutical content, specialist human translation or full specialist human review may be the more appropriate workflow.
Yes, but the level of review should be established before assuming that light post-editing is sufficient.
Fluent AI output can still contain errors in terminology, meaning, omissions or context that may not be immediately obvious. ALM can assess a sample of the translation alongside its intended use and risk profile before recommending an appropriate review process.
For higher-risk pharmaceutical content, this may require full specialist human review rather than limited post-editing. For suitable lower-risk content, AI-assisted workflows can provide significant productivity benefits.
ALM can build and maintain approved terminology databases, glossaries and translation memories using previously approved pharmaceutical content.
This allows terminology to be reused consistently across regulatory documentation, clinical materials, SmPCs, PILs, labelling, safety information and commercial content, while reducing unnecessary retranslation when documents are updated.
For ongoing multilingual programmes, these linguistic assets can form part of a managed Language Operations workflow, connecting terminology, translation memory, technology, automation and specialist human review across products, languages and markets.
Look for demonstrated pharmaceutical or Life Sciences expertise, appropriate specialist linguists, defined quality and review processes, terminology management, secure handling of confidential information and the ability to apply translation technology appropriately to different types of content.
For organisations managing multiple products, languages or regular updates, it is also worth considering whether the provider can build a repeatable multilingual workflow rather than treating every document as an isolated translation project.
ALM is Cyber Essentials accredited and applies defined security and confidentiality controls to client content and supports secure multilingual workflows for sensitive pharmaceutical, clinical and regulatory documentation.
Where AI-assisted technology is appropriate, it is used within controlled workflows rather than placing confidential client content into uncontrolled public AI tools. Client content is not used as public AI training data. Find out more about our AI services.
Related services
SOFTWARE
Medical software localisation
Localise interfaces, help content, product education and supporting documentation while maintaining usability, terminology and consistency across markets.
CLINICAL RESEARCH
Clinical Trial Translation
Communicate clearly across study teams and patient populations with specialist support for clinical, investigator and participant-facing documentation.
INSTRUCTIONS FOR USE
IFU translation
Keep multilingual IFUs accurate, aligned and ready for ongoing updates with specialist terminology, controlled review and scalable version management.
